title: Vitamin k antagonist warfarin for palliative treatment of metachromatic leukodystrophy, a compassionate study of four subjects.
abstract: MLD is characterized by accumulation of sulfatides in the brain. Vitamin K regulates two enzymes in sphingolipid biosynthesis and warfarin is known to lower brain sulfatides in rats and mice. We hypothesized that warfarin may mitigate the MLD phenotype by reducing the formation of sulfatides. This compassionate study recruited four advanced patients with clinical, biochemical and genetic confirmation of MLD. The patients were treated with warfarin according to the approved protocol for a total of 45 days. The battery of tests included proton MR spectroscopy (H-MRS) of brain and urinary sulfatide levels recorded at defined intervals. The patients tolerated the medication and there were no bleeding complications. The urinary sulfatide levels did not decline during the study period. The H-MRS showed decreased N-acetyl aspartate and elevated myoinositol levels in the basal ganglia which remained unchanged after treatment. Our study did not demonstrate any beneficial effects of warfarin in four advanced cases of MLD. The drug intervention however, was safe and deserves further evaluation through a larger study of longer duration. The metabolite abnormalities reported on H-MRS may be useful in longitudinal follow up of patients with MLD during drug trials.
authors: Robert Wood Johnson Medical School.
authors: Mitra
authors: M
authors: Assadi
authors: Dah-Jyuu
authors: DJ
authors: Wang
authors: Kelly
authors: K
authors: Anderson
authors: Melissa
authors: M
authors: Carran
authors: Larissa
authors: L
authors: Bilaniuk
authors: Paola
authors: P
authors: Leone
keywords: MLD; sulfatide sphingolipids; vitamin K; warfarin
references: Bone Marrow Transplant. 2002 Aug;30(4):215-22
references: 12203137
references: Eur J Pediatr. 2008 Mar;167(3):347-52
references: 17387512
references: J Neurol. 1993 Dec;241(2):68-74
references: 7908027
references: Biochem Biophys Res Commun. 1990 Jun 29;169(3):927-32
references: 2363732
references: Blood. 1999 Nov 1;94(9):3007-14
references: 10556183
references: J Nutr. 1996 Nov;126(11):2746-51
references: 8914944
references: J Lipid Res. 1988 Nov;29(11):1475-9
references: 3241123
references: J Lipid Res. 1971 Jul;12(4):434-41
references: 5164093
references: Neuropediatrics. 2010 Feb;41(1):1-6
references: 20571983
references: Pediatr Cardiol. 2000 Jul-Aug;21(4):347-52
references: 10865011
references: Nutr Neurosci. 2003 Dec;6(6):351-9
references: 14744039
references: Nutr Rev. 2005 Apr;63(4):111-21
references: 15869125
references: Neurology. 2010 Nov 23;75(21):1896-903
references: 21098404
references: Curr Opin Hematol. 1999 Nov;6(6):377-82
references: 10546790
references: Arch Biochem Biophys. 1990 Feb 15;277(1):109-13
references: 1968327
references: Arch Biochem Biophys. 1973 Aug;157(2):500-8
references: 4730806
references: Anal Biochem. 1999 May 1;269(2):304-11
references: 10222002
references: J Lipid Res. 1972 May;13(3):364-70
references: 5025467